{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:51:46Z","timestamp":1793278306217,"version":"4.5.0"},"reference-count":54,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cutaneous T-cell lymphomas (CTCLs) are a spectrum of diseases with varied clinical courses caused by malignant clonal proliferation of skin-tropic T cells. Most patients have an indolent disease course managed with skin-directed therapies. In contrast, others, especially in advanced stages of disease or with specific forms, have aggressive progression and poor median survival. S\u00e9zary syndrome (SS), a leukemic variant of CTCL, lacks highly consistent phenotypic and genetic markers that may be leveraged to prevent the delay in\u00a0diagnosis experienced by most patients with CTCL and could be useful for optimal treatment selection. Using single-cell mRNA and T-cell receptor sequencing of peripheral blood immune cells in SS, we extensively mapped the transcriptomic variations of nearly 50\u00a0000 T cells of both malignant and nonmalignant origins. We identified potential diverging SS cell populations, including quiescent and proliferative populations shared across multiple patients. In particular, the expression of AIRE was the most highly upregulated gene in our analysis, and AIRE protein expression could be observed over a variety of CTCLs. Furthermore, within a single patient, we were able to characterize differences in cell populations by comparing malignant T cells over the course of treatment with histone deacetylase inhibition and photopheresis. New cellular clusters after progression of the therapy notably exhibited increased expression of the transcriptional factor FOXP3, a master regulator of regulatory T-cell function, raising the potential implication of an evolving mechanism of immune evasion.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005991","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T19:09:26Z","timestamp":1649358566000},"page":"321-335","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":31,"title":["Single-cell analysis of S\u00e9zary syndrome reveals novel markers and\u00a0shifting gene profiles associated with treatment"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1427-6342","authenticated-orcid":false,"given":"Nicholas","family":"Borcherding","sequence":"first","affiliation":[{"name":"1Department of Pathology, University of Iowa, Iowa City, IA"},{"name":"2Department of Pathology and Immunology, Washington University, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8650-3140","authenticated-orcid":false,"given":"Kevin J.","family":"Severson","sequence":"additional","affiliation":[{"name":"3Department of Dermatology, Mayo Clinic, Scottsdale, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Henderson","sequence":"additional","affiliation":[{"name":"4Department of Dermatology, University of Iowa, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1153-9987","authenticated-orcid":false,"given":"Luana S.","family":"Ortolan","sequence":"additional","affiliation":[{"name":"4Department of Dermatology, University of Iowa, Iowa City, IA"},{"name":"5Seattle Children\u2019s Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison C.","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"6Department of Hematology Oncology, Mayo Clinic, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8264-6379","authenticated-orcid":false,"given":"Andrew M.","family":"Bellizzi","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of Iowa, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1987-9521","authenticated-orcid":false,"given":"Vincent","family":"Liu","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of Iowa, Iowa City, IA"},{"name":"4Department of Dermatology, University of Iowa, Iowa City, IA"},{"name":"7Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5084-0698","authenticated-orcid":false,"given":"Brian K.","family":"Link","sequence":"additional","affiliation":[{"name":"7Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA"},{"name":"8Department of Internal Medicine, University of Iowa, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Mangold","sequence":"additional","affiliation":[{"name":"3Department of Dermatology, Mayo Clinic, Scottsdale, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8559-7314","authenticated-orcid":false,"given":"Ali","family":"Jabbari","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of Iowa, Iowa City, IA"},{"name":"4Department of Dermatology, University of Iowa, Iowa City, IA"},{"name":"7Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA"},{"name":"9Iowa City Veterans Affairs Medical Center, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"issue":"10","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"308","key":"2023021422371401900_","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9122","article-title":"TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL","volume":"7","author":"Kirsch","year":"2015","journal-title":"Sci Transl Med"},{"issue":"10","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1158\/1078-0432.CCR-18-3309","article-title":"Single-cell profiling of cutaneous T-cell lymphoma reveals underlying heterogeneity associated with disease progression","volume":"25","author":"Borcherding","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"16","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/bloodadvances.2018022608","article-title":"Single-cell heterogeneity in S\u00e9zary syndrome","volume":"2","author":"Buus","year":"2018","journal-title":"Blood Adv"},{"issue":"14","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1158\/1078-0432.CCR-19-0148","article-title":"Single-cell lymphocyte heterogeneity in advanced cutaneous T-cell lymphoma skin tumors","volume":"25","author":"Gaydosik","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"29","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1200\/JCO.2010.28.9066","article-title":"Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma","volume":"28","author":"Whittaker","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"32","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1200\/JCO.2008.21.6150","article-title":"Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma","volume":"27","author":"Piekarz","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2017.05.008","article-title":"Chromatin accessibility landscape of cutaneous T cell lymphoma and dynamic response to HDAC inhibitors","volume":"32","author":"Qu","year":"2017","journal-title":"Cancer Cell"},{"key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ebiom.2019.07.053","article-title":"Novel cell adhesion\/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T\u00a0cell lymphoma","volume":"46","author":"Andrews","year":"2019","journal-title":"EBioMedicine"},{"issue":"32","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1200\/JCO.2014.60.3787","article-title":"Results of a phase II trial of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma and lymphomatoid papulosis","volume":"33","author":"Duvic","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"32","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1200\/JCO.2014.60.3969","article-title":"Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and S\u00e9zary syndrome with variable CD30 expression level: a multi-institution collaborative project","volume":"33","author":"Kim","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"issue":"5","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"10","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nmeth.4402","article-title":"Reversed graph embedding resolves complex single-cell trajectories","volume":"14","author":"Qiu","year":"2017","journal-title":"Nat Methods"},{"issue":"8","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1182\/blood-2016-05-716480","article-title":"A\u00a0single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation","volume":"128","author":"Nestorowa","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat Immunol"},{"issue":"1","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/1471-2164-14-632","article-title":"An expression atlas of human primary cells: inference of gene function from coexpression networks","volume":"14","author":"Mabbott","year":"2013","journal-title":"BMC Genomics"},{"issue":"1","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s42003-020-01625-6","article-title":"Mapping the immune environment in clear cell renal carcinoma by single-cell genomics","volume":"4","author":"Borcherding","year":"2021","journal-title":"Commun Biol"},{"issue":"43","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/nar\/27.1.29","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"27","author":"Ogata","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12688\/f1000research.22139.1","article-title":"scRepertoire: an R-based toolkit for single-cell immune receptor analysis","volume":"9","author":"Borcherding","year":"2020","journal-title":"F1000 Res"},{"issue":"W1","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2326-6066.CIR-17-0270","article-title":"Primary t cells from cutaneous t-cell lymphoma skin explants display an exhausted immune checkpoint profile","volume":"6","author":"Querfeld","year":"2018","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"5","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: software for comprehensive adaptive immunity profiling","volume":"12","author":"Bolotin","year":"2015","journal-title":"Nat Methods"},{"issue":"17","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1158\/0008-5472.CAN-08-0602","article-title":"CXCL13 is highly produced by S\u00e9zary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokines","volume":"68","author":"Picchio","year":"2008","journal-title":"Cancer Res"},{"issue":"12","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archdermatol.2012.2089","article-title":"Differential expression of programmed death-1 (PD-1) in S\u00e9zary syndrome and mycosis fungoides","volume":"148","author":"Cetin\u00f6zman","year":"2012","journal-title":"Arch Dermatol"},{"issue":"2","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.leu.2405044","article-title":"S\u00e9zary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3","volume":"22","author":"Booken","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","article-title":"Increased CCR4 expression in cutaneous T cell lymphoma","volume":"119","author":"Ferenczi","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"issue":"117","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"117ra7","DOI":"10.1126\/scitranslmed.3003008","article-title":"Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients","volume":"4","author":"Clark","year":"2012","journal-title":"Sci. Transl Med"},{"issue":"6","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1182\/blood-2010-05-287664","article-title":"High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma","volume":"117","author":"Clark","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nmeth.4380","article-title":"Simultaneous epitope and transcriptome measurement in single cells","volume":"14","author":"Stoeckius","year":"2017","journal-title":"Nat Methods"},{"issue":"5","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41591-018-0008-8","article-title":"Transcript-indexed ATAC-seq for precision immune profiling","volume":"24","author":"Satpathy","year":"2018","journal-title":"Nat Med"},{"issue":"6","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"International Society for Cutaneous Lymphoma. Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.17258","article-title":"The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients","volume":"181","author":"Scarisbrick","year":"2019","journal-title":"Br J Dermatol"},{"issue":"16","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood.2020009346","article-title":"Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures","volume":"138","author":"Herrera","year":"2021","journal-title":"Blood"},{"issue":"14","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1182\/blood-2010-07-294819","article-title":"Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL\/CD95L transcription","volume":"117","author":"Wang","year":"2011","journal-title":"Blood"},{"issue":"21","key":"2023021422371401900_","first-page":"7122","article-title":"Aberrant expression of T-plastin in Sezary cells","volume":"63","author":"Su","year":"2003","journal-title":"Cancer Res"},{"issue":"6","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/jid.2012.13","article-title":"Molecular markers of early-stage mycosis fungoides","volume":"132","author":"Zhang","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"issue":"9","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1182\/blood-2014-05-571778","article-title":"Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma","volume":"125","author":"Huang","year":"2015","journal-title":"Blood"},{"key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"666935","DOI":"10.3389\/fimmu.2021.666935","article-title":"Single-cell RNA sequencing reveals tissue compartment-specific plasticity of mycosis fungoides tumor cells","volume":"12","author":"Rindler","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri.2016.9","article-title":"AIRE expands: new roles in immune tolerance and beyond","volume":"16","author":"Anderson","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaut.2010.07.008","article-title":"Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population","volume":"35","author":"Laakso","year":"2010","journal-title":"J\u00a0Autoimmun"},{"issue":"4","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/sj.jid.5700371","article-title":"Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma","volume":"126","author":"Tiemessen","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"issue":"12","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/leu.2008.224","article-title":"Malignant Tregs express low molecular splice forms of FOXP3 in S\u00e9zary syndrome","volume":"22","author":"Krejsgaard","year":"2008","journal-title":"Leukemia"},{"issue":"12","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","article-title":"FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival","volume":"21","author":"Gjerdrum","year":"2007","journal-title":"Leukemia"},{"issue":"5","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41408-020-0324-3","article-title":"Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in S\u00e9zary syndrome","volume":"10","author":"Willerslev-Olsen","year":"2020","journal-title":"Blood Cancer J"},{"issue":"16","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1182\/blood-2012-04-423061","article-title":"Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts","volume":"120","author":"Lee","year":"2012","journal-title":"Blood"},{"issue":"229","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2002873","article-title":"Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms","volume":"5","author":"Beier","year":"2012","journal-title":"Sci Signal"},{"issue":"153","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fmed.2017.00153","article-title":"TruSeq-based gene expression analysis of formalin-fixed paraffin-embedded (FFPE) cutaneous T-cell lymphoma samples: subgroup analysis results and elucidation of biases from FFPE sample processing on the TruSeq platform","volume":"4","author":"Lefran\u00e7ois","year":"2017","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"2023021422371401900_","doi-asserted-by":"crossref","first-page":"e1306618","DOI":"10.1080\/2162402X.2017.1306618","article-title":"Gene expression analysis in cutaneous T-cell lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators","volume":"6","author":"Litvinov","year":"2017","journal-title":"OncoImmunology"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/3\/321\/2033462\/blooda_adv-2021-005991-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/3\/321\/2033462\/blooda_adv-2021-005991-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T19:50:29Z","timestamp":1700423429000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/3\/321\/484633\/Single-cell-analysis-of-Sezary-syndrome-reveals"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005991","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]}}}